{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:12:41Z","timestamp":1794305561436,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s13555-022-00788-w","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:02:50Z","timestamp":1661144570000},"page":"2189-2200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series"],"prefix":"10.1007","volume":"12","author":[{"given":"James Q.","family":"Del Rosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-1251","authenticated-orcid":false,"given":"Edward","family":"Lain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"788_CR1","doi-asserted-by":"crossref","unstructured":"Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S98\u2013106.","DOI":"10.1067\/mjd.2002.120791"},{"issue":"6","key":"788_CR2","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/bjd.17608","volume":"180","author":"JC Lester","year":"2019","unstructured":"Lester JC, Taylor SC, Chren MM. Under-representation of skin of colour in dermatology images: not just an educational issue. Br J Dermatol. 2019;180(6):1521\u20132.","journal-title":"Br J Dermatol"},{"issue":"1","key":"788_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40257-013-0049-1","volume":"15","author":"NC Yin","year":"2014","unstructured":"Yin NC, McMichael AJ. Acne in patients with skin of color: practical management. Am J Clin Dermatol. 2014;15(1):7\u201316.","journal-title":"Am J Clin Dermatol"},{"issue":"3s","key":"788_CR4","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.12788\/j.sder.2018.027","volume":"37","author":"AF Alexis","year":"2018","unstructured":"Alexis AF, Harper JC, Stein Gold LF, Tan JKL. Treating acne in patients with skin of color. Semin Cutan Med Surg. 2018;37(3s):S71\u20133.","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"788_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40257-021-00643-2","volume":"23","author":"VD Callender","year":"2022","unstructured":"Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2022;23(1):69\u201381.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"788_CR6","first-page":"s61","volume":"13","author":"AF Alexis","year":"2014","unstructured":"Alexis AF. Acne vulgaris in skin of color: understanding nuances and optimizing treatment outcomes. J Drugs Dermatol. 2014;13(6):s61\u20135.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"788_CR7","first-page":"716","volume":"20","author":"AF Alexis","year":"2021","unstructured":"Alexis AF, Woolery-Lloyd H, Williams K, et\u00a0al. Racial\/ethnic variations in acne: implications for treatment and skin care recommendations for acne patients with skin of color. J Drugs Dermatol. 2021;20(7):716\u201325.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"788_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13555-017-0185-2","volume":"7","author":"J Leyden","year":"2017","unstructured":"Leyden J, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatol Ther (Heidelb). 2017;7(3):293\u2013304.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"788_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40257-021-00594-8","volume":"22","author":"H Baldwin","year":"2021","unstructured":"Baldwin H, Webster G, Stein Gold L, Callender V, Cook-Bolden FE, Guenin E. 50 years of topical retinoids for acne: evolution of treatment. Am J Clin Dermatol. 2021;22(3):315\u201327.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"788_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.bmcl.2018.04.036","volume":"28","author":"E Thoreau","year":"2018","unstructured":"Thoreau E, Arlabosse JM, Bouix-Peter C, et\u00a0al. Structure-based design of trifarotene (CD5789), a potent and selective RAR\u03b3 agonist for the treatment of acne. Bioorg Med Chem Lett. 2018;28(10):1736\u201341.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"788_CR11","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"J Tan","year":"2019","unstructured":"Tan J, Thiboutot D, Popp G, et\u00a0al. Randomized phase 3 evaluation of trifarotene 50 \u03bcg\/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"788_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/jdv.15794","volume":"34","author":"U Blume-Peytavi","year":"2020","unstructured":"Blume-Peytavi U, Fowler J, Kem\u00e9ny L, et\u00a0al. Long-term safety and efficacy of trifarotene 50 \u03bcg\/g cream, a first-in-class RAR-\u03b3 selective topical retinoid, in patients with moderate facial and truncal acne. J Eur Acad Dermatol Venereol. 2020;34(1):166\u201373.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"788_CR13","first-page":"19","volume":"8","author":"JQ Del Rosso","year":"2015","unstructured":"Del Rosso JQ. Oral doxycycline in the management of acne vulgaris: current perspectives on clinical use and recent findings with a new double-scored small tablet formulation. J Clin Aesthet Dermatol. 2015;8(5):19\u201326.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"788_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, et\u00a0al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33.","journal-title":"J Am Acad Dermatol"},{"key":"788_CR15","unstructured":"US Food and Drug Administration. Summary of product characteristics. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211527s000lbl.pdf. Accessed 28 Feb 2022."},{"issue":"5","key":"788_CR16","first-page":"18","volume":"10","author":"K Darji","year":"2017","unstructured":"Darji K, Varade R, West D, Armbrecht ES, Guo MA. Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris. J Clin Aesthet Dermatol. 2017;10(5):18\u201323.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"788_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1590\/abd1806-4841.20175645","volume":"92","author":"K Fran\u00e7a","year":"2017","unstructured":"Fran\u00e7a K, Keri J. Psychosocial impact of acne and postinflammatory hyperpigmentation. An Bras Dermatol. 2017;92(4):505\u20139.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"788_CR18","first-page":"8223","volume":"13","author":"F Al-Qarqaz","year":"2021","unstructured":"Al-Qarqaz F, Bodoor K, Baba A, Al-Yousef A, Muhaidat J, Alshiyab D. Post-acne hyperpigmentation: evaluation of risk factors and the use of artificial neural network as a predictive classifier. Dermatol Rep. 2021;13(3):8223.","journal-title":"Dermatol Rep"},{"issue":"4","key":"788_CR19","volume":"14","author":"A Afrin","year":"2022","unstructured":"Afrin A, Cohen PR. Doxycycline-associated hyperpigmentation: a case report and literature review. Cureus. 2022;14(4): e23754.","journal-title":"Cureus"},{"issue":"20","key":"788_CR20","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","volume":"328","author":"SM Bulengo-Ransby","year":"1993","unstructured":"Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et\u00a0al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in Black patients. N Engl J Med. 1993;328(20):1438\u201343.","journal-title":"N Engl J Med"},{"issue":"1","key":"788_CR21","first-page":"45","volume":"77","author":"P Grimes","year":"2006","unstructured":"Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45\u201350.","journal-title":"Cutis"},{"issue":"Suppl 3","key":"788_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.0926-9959.2001.00011.x","volume":"15","author":"WK Jacyk","year":"2001","unstructured":"Jacyk WK. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15(Suppl 3):37\u201342.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"788_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/1346-8138.14314","volume":"45","author":"JA See","year":"2018","unstructured":"See JA, Goh CL, Hayashi N, Suh DH, Casintahan FA. Optimizing the use of topical retinoids in Asian acne patients. J Dermatol. 2018;45(5):522\u20138.","journal-title":"J Dermatol"},{"issue":"6","key":"788_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40257-021-00633-4","volume":"22","author":"N Elbuluk","year":"2021","unstructured":"Elbuluk N, Grimes P, Chien A, et\u00a0al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22(6):829\u201336.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"788_CR25","first-page":"442","volume":"179","author":"J Aubert","year":"2018","unstructured":"Aubert J, Piwnica D, Bertino B, et\u00a0al. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-\u03b3 agonist trifarotene. Br J Dermatol. 2018;179(2):442\u201356.","journal-title":"Br J Dermatol"},{"issue":"1","key":"788_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1060028020934892","volume":"55","author":"KA Bell","year":"2021","unstructured":"Bell KA, Brumfiel CM, Haidari W, Boger L. Trifarotene for the treatment of facial and truncal acne. Ann Pharmacother. 2021;55(1):111\u20136.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"788_CR27","first-page":"401","volume":"13","author":"SJ Kang","year":"2014","unstructured":"Kang SJ, Davis SA, Feldman SR, McMichael AJ. Dyschromia in skin of color. J Drugs Dermatol. 2014;13(4):401\u20136.","journal-title":"J Drugs Dermatol"},{"key":"788_CR28","doi-asserted-by":"crossref","unstructured":"Goh CL, Tang MB, Briantais P, Kaoukhov A, Soto P. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins. J Dermatol Treat. 2009;20(5):282\u20138.","DOI":"10.1080\/09546630902763164"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00788-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00788-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00788-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T04:35:42Z","timestamp":1662784542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00788-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00788-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}